Literature DB >> 30746943

Genome Mining of Streptomyces atratus SCSIO ZH16: Discovery of Atratumycin and Identification of Its Biosynthetic Gene Cluster.

Changli Sun1, Zhijie Yang1,2, Chunyan Zhang1,2, Zhiyong Liu3, Jianqiao He1,2, Qing Liu1,4, Tianyu Zhang3,2, Jianhua Ju1,2, Junying Ma1.   

Abstract

Genome mining of the deep sea-derived Streptomyces atratus SCSIO ZH16 enabled the activation of a cyclodepsipeptide gene cluster and isolation of its cinnamic acid-bearing product, atratumycin (1). Atratumycin's structure was elucidated on the basis of extensive spectroscopic experiments, X-ray data, and Marfey's method; a plausible biosynthesis and tailoring modification of 1 are also proposed and investigated. Additionally, atratumycin is active against Mycobacteria tuberculosis H37Ra and H37Rv with MICs of 3.8 and 14.6 μM, respectively.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30746943     DOI: 10.1021/acs.orglett.9b00208

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  17 in total

Review 1.  Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications.

Authors:  Zhong Li; Yuanyuan Jiang; F Peter Guengerich; Li Ma; Shengying Li; Wei Zhang
Journal:  J Biol Chem       Date:  2019-12-06       Impact factor: 5.157

2.  Genome Mining and Metabolomics Unveil Pseudonochelin: A Siderophore Containing 5-Aminosalicylate from a Marine-Derived Pseudonocardia sp. Bacterium.

Authors:  Fan Zhang; René F Ramos Alvarenga; Kurt Throckmorton; Shaurya Chanana; Doug R Braun; Jen Fossen; Miao Zhao; Sue McCrone; Mary Kay Harper; Scott R Rajski; Warren E Rose; David R Andes; Michael G Thomas; Tim S Bugni
Journal:  Org Lett       Date:  2022-06-01       Impact factor: 6.072

3.  Youssoufenes A2 and A3, Antibiotic Dimeric Cinnamoyl Lipids from the ΔdtlA Mutant of a Marine-Derived Streptomyces Strain.

Authors:  Jing Liu; Huayue Li; Zengzhi Liu; Tong Li; Fei Xiao; Wenli Li
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

Review 4.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

5.  Aggregatimonas sangjinii gen. nov., sp. nov., a novel silver nanoparticle synthesizing bacterium belonging to the family Flavobacteriaceae.

Authors:  Dawoon Chung; Jaejoon Jung; Jaoon Young Hwan Kim; Kyung Woo Kim; Yong Min Kwon
Journal:  Antonie Van Leeuwenhoek       Date:  2022-01-23       Impact factor: 2.271

6.  Characterization of the Noncanonical Regulatory and Transporter Genes in Atratumycin Biosynthesis and Production in a Heterologous Host.

Authors:  Zhijie Yang; Xin Wei; Jianqiao He; Changli Sun; Jianhua Ju; Junying Ma
Journal:  Mar Drugs       Date:  2019-09-29       Impact factor: 5.118

7.  Genome Sequencing of Streptomyces olivaceus SCSIO T05 and Activated Production of Lobophorin CR4 via Metabolic Engineering and Genome Mining.

Authors:  Chunyan Zhang; Wenjuan Ding; Xiangjing Qin; Jianhua Ju
Journal:  Mar Drugs       Date:  2019-10-20       Impact factor: 5.118

8.  Desert Environments Facilitate Unique Evolution of Biosynthetic Potential in Streptomyces.

Authors:  Kunjukrishnan Kamalakshi Sivakala; Karina Gutiérrez-García; Polpass Arul Jose; Thangadurai Thinesh; Rangasamy Anandham; Francisco Barona-Gómez; Natesan Sivakumar
Journal:  Molecules       Date:  2021-01-22       Impact factor: 4.411

9.  Genome Characteristics Reveal the Biocontrol Potential of Actinobacteria Isolated From Sugarcane Rhizosphere.

Authors:  Zhen Wang; Manoj Kumar Solanki; Zhuo-Xin Yu; Muhammad Anas; Deng-Feng Dong; Yong-Xiu Xing; Mukesh Kumar Malviya; Fei Pang; Yang-Rui Li
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

Review 10.  Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization.

Authors:  Anne-Sofie De Rop; Jeltien Rombaut; Thomas Willems; Marilyn De Graeve; Lynn Vanhaecke; Paco Hulpiau; Sofie L De Maeseneire; Maarten L De Mol; Wim K Soetaert
Journal:  Mar Drugs       Date:  2021-12-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.